Navigation Links
Not the protein, but its location in the cell, determines the onset of leukemia
Date:7/10/2008

kinase inhibitors are usually used to combat these kinds of cancers. However, the carcinogenic kinase often becomes resistant to these inhibitors − which is certainly true for T-ALL. So, scientists are actively seeking alternative approaches.

De Keersmaecker's recent research results now offer a possibility. Indeed, the scientists have shown in cells that NUP214-ABL1 is no longer carcinogenic when it cannot bind with the protein complex in the vicinity of the cell nucleus. On the basis of these results, the researchers want to further investigate the therapeutic possibilities of compounds that render binding between the complex and NUP214-ABL1 impossible. This study also indicates that the location of proteins can play an important role in other forms of cancer/leukemia as well.


'/>"/>

Contact: Joke Comijn
Joke.comijn@vib.be
329-244-6611
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
2. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
3. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
4. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
5. Surface dislocation nucleation: Strength is but skin deep at the nanoscale, Penn engineers discover
6. Caliper Life Sciences Announces Date and Location of its 2008 Annual Meeting of Stockholders
7. Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis
8. RainDance Announces Company Relocation and Manufacturing Startup
9. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
10. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... (PRWEB) June 20, 2013 The ... outcomes measurement because of variability in Patient-Reported Outcomes ... sensitivity of such scales to culture, their cross-cultural ... laboratory testing for the successful development of a ... steps for maximizing cross-cultural equivalence of scales assessing ...
(Date:6/20/2013)... 20, 2013 Based on its recent ... Sullivan presents bitop AG with the 2013 European ... The company,s path-breaking extremolyte platform enables a naturally-derived ... dry eye or dry nose syndrome, and respiratory ... to revolutionize how allergies are treated. ...
(Date:6/20/2013)... June 20, 2013 Over the years, ... has received many questions that can be summed up in ... Owner of GLM Displays, Matt Lunser, sat down and ... between his products and offer some useful tips on how ... , “This buyer's guide is meant to help our clients ...
(Date:6/20/2013)... Belatrix Software, the leading global Nearshore Agile ... latest initiative – the Belatrix Software Innovation University (BSIU). ... and business and technology executives to participate in a ... the initiative is to fuel business leaders with what ... innovation efforts. It’s that inspiration that has the ...
Breaking Biology Technology:Cross-Cultural Qualitative Research for Simultaneous Scale Development, New Life Science Webinar Hosted by Xtalks 2Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 2Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 3Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market 4Belatrix Software Kicks off Major Innovation Effort and Invites Innovation Expert to Share How Agile + Design Thinking Accelerate Product Innovation 2
... ways to improve infrared photodetector technology that is critical ... used increasingly in commercial applications and consumer products. ... in the journal Applied Physics Letters ... be done more effectively by using certain materials arranged ...
... N.J., Feb. 14, 2012 Laureate Biopharmaceutical ... and manufacturing organization, today announced the appointment ... He will be responsible for continuing Laureate,s ... This will include preparing for upcoming pre-approval ...
... The Foundation for Angelman Syndrome Therapeutics (FAST) announces ... a potential treatment for the rare genetic disorder, Angelman ... Angelman Syndrome study will examine if the off ... symptoms associated with Angelman Syndrome. Minocycline, an FDA approved ...
Cached Biology Technology:New nano-material combinations produce leap in infrared technology 2New nano-material combinations produce leap in infrared technology 3Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations 2Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations 3Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial 2Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial 3
(Date:6/19/2013)... at the University of Pittsburgh has developed antibacterial ... that could be potential treatments for drug-resistant bacterial ... new agents are quite small, making them inexpensive ... in the June 2013 issue of the journal ... first of many probable applications will likely be ...
(Date:6/19/2013)... June 19, 2013 A decade-long JDRF-funded study ... Helmholtz Zentrum Mnchen, Germany, is providing a deeper ... risk of developing type 1 diabetes (T1D), highlighting ... for the disease. The study, "Seroconversion to Multiple ... in Children," was published today in The ...
(Date:6/19/2013)... how pearls form into the most perfectly spherical large ... are proposing in a new study. It appears in ... Laureate Irving Langmuir. , Julyan Cartwright, Antonio G. Checa ... and highly prized pearls have perhaps the most perfectly ... nature that are visible without a microscope. Pearls develop ...
Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2New data on islet autoantibodies in young children defines early type 1 diabetes development 2
... your bananas are more than pests—they may be allies ... caused when genes malfunction. , "One common misconception is ... a gene for cancer," explains James Erickson, a biology ... the same genes, but individual genes have different forms, ...
... 50 million people died during a worldwide influenza pandemic ... influenza virus. Recently H5N1, another highly infectious avian strain ... There is great concern that this virus might also ... pandemic. Specific mutations in a viral protein, the polymerase, ...
... Media Lab have invented a way to reversibly silence ... prospect of controlling the haywire neuron activity that occurs ... Such diseases often must be treated by removing neurons ... to the development of optical brain prosthetics to control ...
Cached Biology News:Fruit fly gene research may shed light on human disease processes 2Fruit fly gene research may shed light on human disease processes 3A first glimpse of the influenza replication machine 2MIT: Pulsing light silences overactive neurons 2
PGD2-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGD2 by GC- or LC-mass spectrometry....
Request Info...
...
Human Aminopeptidase P1/XPNPEP1 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Biology Products: